The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
E-cigarette maker Juul Labs Inc.'s sales have been halted on two websites in China, just days after it launched in the world's biggest tobacco market.Biotech and Pharmaceuticalsread more
Investors might be wary that gasoline prices will continue to rise, and are looking to take back profits by selling off shares.Retailread more
The Trump administration move on California's auto emissions standards would likely set up a fight between the White House and the state.Politicsread more
"I feel really confident that defense-minded CEOs, when they are on defense, they're going to come to" flexible offices and away from traditional leases, Knotel CEO Amol Sarva...Commercial Real Estateread more
Fanatics has hired Michener Chandlee, Nike's corporate audit and chief risk officer, to become its chief financial officer, succeeding Lauren Cooks Levitan, CNBC has learned.Retailread more
Potbot uses AI to "read" through peer-reviewed medical journals to find studies on cannabinoids, the active compounds in marijuana. Using the research, it pairs 37 symptoms like insomnia, asthma and cancer with branded marijuana strains to find which type of weed is best suited to treat each one.
The company has raised $5 million to date, according to Potbotics CEO David Goldstein. Part of the reason for its success is the technology doesn't actually involve marijuana directly, making it completely legal he said. The app is available in Apple's App Store and the Google Play store. In addition, the bigger pharmaceutical companies haven't entered the space, giving the marijuana industry a "start-up mentality."
"We definitely see there's interest in the industry, for sure," Goldstein said. "It's one that has real potential in the United States and internationally. A lot of investors like non-cannabis touching entities, because they feel like they are hedging their bets a little bit."
There are some challenges, including having to look at state-by-state regulations instead of being able to scale quickly like other tech companies, he pointed out. Potbotics is focusing in the New England area for now.
Goldstein, who called the legalization of medical marijuana a "lifelong passion" of his, got the idea for Potbot after a family member got sick. There are two different cultures of marijuana users – those who seek it out for medicinal purposes versus those who use it recreationally, he said.
"She refused to get this medicine because she felt it wasn't a professional experience," Goldstein said. "There are great applications like Leafly and Weedmaps. We didn't feel like there was something that helps hit that medical patient."
Goldstein previously started a crowdfunding and marketing company called Crowdpunch, so he had experience in running a company. However, he had to convince father and co-founder Baruch Goldstein to get on board. Baruch, who holds a PhD in Mathematics, completed previous work pairing artificial intelligence with medical research. One of his projects involved using AI to finding botanical strains that would help treat pre-Alzheimer's patients.
"It was a little bit of an uphill battle convincing him, but he met some of the medical marijuana patients I introduced him too," said Goldstein. "He realized if you take a real medical approach it was the same."